✦ LIBER ✦

Inhibition of heme oxygenase-1 with an epidermal growth factor receptor inhibitor and cisplatin decreases proliferation of lung cancer A549 cells

✍ Scribed by Kuroda, Hideyo; Takeno, Mitsuhiro; Murakami, Shuji; Miyazawa, Naoki; Kaneko, Takeshi; Ishigatsubo, Yoshiaki

Book ID: 119320152
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 565 KB
Volume: 67
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2009.03.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of Epidermal Growth Factor Recept

Effect of Epidermal Growth Factor Receptor Inhibitor Alone and in Combination with Cisplatin on Growth of Vulvar Cancer Cells

✍ Su-Hyeon Kim; Yoo-Cheol Song; Su-Hyeong Kim; Hoenil Jo; Yong-Sang Song 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB

Epidermal growth factor receptor mutatio

Epidermal growth factor receptor mutations and their correlation with epidermal growth factor receptor-tyrosine kinase inhibitor therapy and association with the characteristics of patients with non-small-cell lung cancer: A meta-analysis

✍ Xiao-Hang Zhang; Cheng Li; Chen-Fei Dai; Bao-Sen Zhou 📂 Article 📅 2011 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 203 KB

The effect of ZD1839 (IressaTM), an epid

The effect of ZD1839 (IressaTM), an epidermal growth factor receptor tyrosine kinase inhibitor, in combination with cisplatin, on apoptosis in SCC-15 cells

✍ A. Al-Hazzaa; I. D. Bowen; P. Randerson; M. A. Birchall 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

Phase II Data with ZD6474, a Small-Molec

Phase II Data with ZD6474, a Small-Molecule Kinase Inhibitor of Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor Receptor, in Previously Treated Advanced Non–Small-Cell Lung Cancer

✍ David Lee; Ronald B. Natale; Eric Nadler; Vinay K. Jain 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 77 KB

Inhibition of proliferation and inductio

Inhibition of proliferation and induction of apoptosis in breast cancer cells by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 (‘Iressa’) is independent of EGFR expression level

✍ Manuela Campiglio; Alberta Locatelli; Clelia Olgiati; Nicola Normanno; Giulia So 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 2 views

High expression of the epidermal growth factor receptor (EGFR) in breast carcinoma confers a growth advantage to the tumor cells. The EGFR tyrosine kinase inhibitor (EGFR-TKI) ZD1839 ('Iressa') has clinical activity in a wide range of tumor types, although the mechanism(s) by which it exerts its ant

MDA-468, a human breast cancer cell line

MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF

✍ Jorge Filmus; Michael N. Pollak; Relda Cailleau; Ronald N. Buick 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 944 KB